UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition
Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects Â
British pharmacies and slimming clinics are reducing prices for weight-loss...
Supply of GLP-1 RAs not expected to return to normal until the end of 2024, says DHSC
Clinicians have been instructed to avoid prescribing GLP-1 receptor agonists for off-label indications
The Department of Health and Social Care (DHSC) has issued an...
MHRA identifies two UK wholesalers selling Ozempic
There is no evidence of the falsified pens being dispensed to UK patients’
The Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that Ozempic has...
‘Wegovy could be key to curing heart failure’
Novo Nordisk said its hugely popular drug Wegovy was shown to substantially ease heart failure in obese people, as the Danish drugmaker seeks to...
Weight loss drug candidates multiply, spurring hopes of lower costs
New data on weight loss drugs that could compete with Novo Nordisk's Wegovy are raising expectations there will soon be more options, and possibly...
Novo Nordisk invests £1.8 bln in Danish production facility
Hot on the heels of its popularity over weight-loss drug Wegovy, Danish drugmaker Novo Nordisk is to invest £1.8 billion to expand a production...